Cargando…
Pharmacological Treatments for Patients with Treatment-Resistant Depression
Over a third of patients with major depressive disorder (MDD) do not have an adequate response to first-line antidepressant treatments, i.e., they have treatment-resistant depression (TRD). These patients tend to have a more severe course of illness and are at an increased risk of suicide. Next step...
Autores principales: | Ruberto, Valerie L., Jha, Manish K., Murrough, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345023/ https://www.ncbi.nlm.nih.gov/pubmed/32512768 http://dx.doi.org/10.3390/ph13060116 |
Ejemplares similares
-
Spotlight on Pimavanserin Tartrate and Its Therapeutic Potential in the Treatment of Major Depressive Disorder: The Evidence to Date
por: Soogrim, Vicki, et al.
Publicado: (2021) -
Pharmacological and Non-pharmacological Treatment Options for Depression and Depressive Symptoms in Hemodialysis Patients
por: Grigoriou, Stefania S., et al.
Publicado: (2015) -
Pharmacologic treatment of depression in patients with myocardial infarction
por: Ha, Jeong-Hoon, et al.
Publicado: (2011) -
Novel Pharmacological Approaches to the Treatment of Depression
por: Elias, Elias, et al.
Publicado: (2022) -
Pharmacological approaches to the challenge of treatment-resistant depression
por: Ionescu, Dawn F., et al.
Publicado: (2015)